Sign in

CIK 0000944809

  • Accelerated filer

OPKO HEALTH, INC.

Sign in to watch
Ticker
OPK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
752402409
Phone
+1 305-575-4181
Business address
4400 BISCAYNE BLVD., MIAMI, FL, 33137
Former names
EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
  1. 4 Open-market buy CEO & Chairman bought 150,000 shares at $1.47 ($220,425)
  2. 4 Open-market buy CEO & Chairman bought 500,000 shares at $1.48 ($740,850)
  3. 4 Open-market buy CEO & Chairman bought 125,000 shares at $1.60 ($199,375)
  4. 4 Open-market buy CEO & Chairman bought 500,000 shares at $1.56 ($781,050)
  5. 4 Open-market buy CEO & Chairman bought 199,072 shares at $1.53 ($305,376)
  6. 4 Open-market buy CEO & Chairman bought 100,000 shares at $1.59 ($159,000)
  7. 4/A Open-market buy CEO & Chairman bought 280,183 shares at $1.50 ($421,535)
  8. 4 Open-market buy CEO & Chairman bought 100,000 shares at $1.62 ($161,980)
  9. 4 Open-market buy CEO & Chairman bought 280,183 shares at $1.50 ($421,535)
  10. 4 Derivatives Options or other derivatives
  11. 4/A Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale 10% owner sold 139,824 shares at an average $34.02 ($4,756,875)
  14. 4 Open-market sale 10% owner sold 84,774 shares at an average $34.19 ($2,898,314)
  15. 4 Open-market sale 10% owner sold 112,994 shares at an average $31.54 ($3,563,807)
  16. 4 Open-market sale 10% owner sold 88,839 shares at $33.50 ($2,976,346)
  17. 4 Open-market sale 10% owner sold 50,000 shares at $33.86 ($1,692,890)
  18. 4 Open-market sale 10% owner sold 135,000 shares at an average $33.78 ($4,560,363)
  19. 4 Grant or award CEO & Chairman acquired 500,000 shares (grant or award)
  20. 4 Grant or award Vice Chairman & CTO acquired 500,000 shares (grant or award)

Page 3 of 106 · 2,118 filings